These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24656316)

  • 1. Cost-utility analysis of sodium polystyrene sulfonate vs. potential alternatives for chronic hyperkalemia.
    Little DJ; Nee R; Abbott KC; Watson MA; Yuan CM
    Clin Nephrol; 2014 Apr; 81(4):259-68. PubMed ID: 24656316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Little D, Nee R, Abbott K, et al. Cost utility analysis of sodium polystyrene sulfate vs. potential alternatives for chronic hyperkalemia. Clinical Nephrology, 2014; 81: 259-268.
    Straube B; Reaven N; Funk S
    Clin Nephrol; 2015 Jun; 83(6):380-1. PubMed ID: 26221659
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L; Dufour AC; Doiron J; Handfield K; Desforges K; Bell R; Vallée M; Savoie M; Perreault S; Laurin LP; Pichette V; Lafrance JP
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2136-42. PubMed ID: 26576619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
    Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE
    Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia.
    Bounthavong M; Butler J; Dolan CM; Dunn JD; Fisher KA; Oestreicher N; Pitt B; Hauptman PJ; Veenstra DL
    Pharmacoeconomics; 2018 Dec; 36(12):1463-1473. PubMed ID: 30194623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium polystyrene sulfonate: a cation exchange resin used in treating hyperkalemia.
    Meyer I
    ANNA J; 1993 Feb; 20(1):93-5. PubMed ID: 8431031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age.
    Noel JA; Bota SE; Petrcich W; Garg AX; Carrero JJ; Harel Z; Tangri N; Clark EG; Komenda P; Sood MM
    JAMA Intern Med; 2019 Aug; 179(8):1025-1033. PubMed ID: 31180477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy.
    Schaefer JA; Gales MA
    Ann Pharmacother; 2016 Jun; 50(6):502-10. PubMed ID: 27009290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysulfonate Resins in Hyperkalemia: A Systematic Review.
    Wong SWS; Zhang G; Norman P; Welihinda H; Wijeratne DT
    Can J Kidney Health Dis; 2020; 7():2054358120965838. PubMed ID: 33240515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of sodium zirconium cyclosilicate for treating hyperkalemia among Chinese patients.
    Tian L; Fu S; Li M; Zhao X; Li H
    Front Public Health; 2023; 11():1196789. PubMed ID: 38145082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy.
    Chernin G; Gal-Oz A; Ben-Assa E; Schwartz IF; Weinstein T; Schwartz D; Silverberg DS
    Clin Cardiol; 2012 Jan; 35(1):32-6. PubMed ID: 22057933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperkalemia and potential pitfalls of sodium polystyrene sulfonate.
    Nguyen T; Ondrik D; Zhufyak O; To W; He S
    JAAPA; 2015 Mar; 28(3):41-5. PubMed ID: 25710403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs to prevent and treat hyperkalemia.
    Lepage L; Desforges K; Lafrance JP
    Curr Opin Nephrol Hypertens; 2016 Nov; 25(6):524-528. PubMed ID: 27584929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
    Hagan AE; Farrington CA; Wall GC; Belz MM
    Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of sodium zirconium cyclosilicate for advanced chronic kidney patients in Singapore.
    Chay J; Choo JCJ; Finkelstein EA
    Nephrology (Carlton); 2024 May; 29(5):278-287. PubMed ID: 38443742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium polystyrene sulfonate resin candy for control of potassium in chronic dialysis patients.
    Johnson K; Cazee C; Gutch C; Ogden D
    Clin Nephrol; 1976 Jun; 5(6):266-8. PubMed ID: 1277599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Hyperkalemia in Heart Failure and the Therapeutic Use of Potassium Binders.
    Sarwar CMS; Bhagat AA; Anker SD; Butler J
    Handb Exp Pharmacol; 2017; 243():537-560. PubMed ID: 28382468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.
    Davidson JP; King AJ; Kumaraswamy P; Caldwell JS; Korner P; Blanks RC; Jacobs JW
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):244-253. PubMed ID: 29130735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium Binders for Hyperkalemia in Chronic Kidney Disease-Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis.
    Palmer BF
    Mayo Clin Proc; 2020 Feb; 95(2):339-354. PubMed ID: 31668450
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.